
Ireland latest to suspend AstraZeneca Covid-19 vaccine
It is temporarily suspending the shot 'out of an abundance of caution' after Norway reported serious blood clotting.

It is temporarily suspending the shot 'out of an abundance of caution' after Norway reported serious blood clotting.

They're being treated in the hospital for bleeding, blood clots and a low count of blood platelets.

It is currently reviewing the reports and will revert on its findings.

Some take early precautions pending an investigation, while others see insufficient evidence to stop vaccinations.

They're worried about side-effects, sceptical it was effective against new variants of Covid-19.

Health officials probing 8 deaths after receiving AstraZeneca Covid-19 vaccine found no evidence shots played a role.

COVID-19 | Health minister assures that safety is the utmost priority in approving a Covid-19 vaccine.

Early results indicated AstraZeneca vaccine less effective against the South African variant.

South Korean news agency reports that both deceased had pre-existing conditions.

The AstraZeneca Covid-19 vaccine was yesterday granted conditional registration approval in Malaysia.

COVID-19 | This brings to three the number of vaccines in Malaysia's arsenal against the pandemic.

These vaccines use a harmless virus as a vehicle, but the body can develop defences against it too.


There's no proof the vaccine is less effective, says its health minister.

Data shows the vaccine gave minimal protection against mild-to-moderate infection caused by South African variant.

However, some European countries say more data is needed before it is given to those over 65.

Confusion and anger infect Europe over vaccine supply.

This vaccine is to tackle the new variants of Covid-19, the drug maker announces.

The actual number of vaccines may change due to manufacturing and other constraints.

AstraZeneca CEO does not commit the company to a specific timetable for deliveries.

UPDATED 4.30PM | COVID-19 | Cost will cover procurement of 55 freezers, says Khairy Jamaluddin.

Zydus Cadila’s ZyCoV-D and Russia’s Sputnik V vaccines are both on trial in India.

Differences in efficacy rates, storage temperatures, and prices.

Britain has ordered 100 million doses of this vaccine.